Morpholine → HCID 59733004, compound
Reaction equation
[F:1][C:2]1[CH:25]=[CH:24][CH:23]=[C:22]([O:26][CH3:27])[C:3]=1[O:4][C:5]1[CH:10]=[CH:9][C:8]([CH:11]=O)=[CH:7][C:6]=1[NH:13][C:14]([NH:16][C:17]1[S:18][CH:19]=[CH:20][N:21]=1)=[O:15].[NH:28]1[CH2:33][CH2:32][O:31][CH2:30][CH2:29]1>>[F:1][C:2]1[CH:25]=[CH:24][CH:23]=[C:22]([O:26][CH3:27])[C:3]=1[O:4][C:5]1[CH:10]=[CH:9][C:8]([CH2:11][N:28]2[CH2:33][CH2:32][O:31][CH2:30][CH2:29]2)=[CH:7][C:6]=1[NH:13][C:14]([NH:16][C:17]1[S:18][CH:19]=[CH:20][N:21]=1)=[O:15]Participants
3
Procedure
1-[2-(2-Fluoro-6-methoxy-phenoxy)-5-morpholin-4-ylmethyl-phenyl]-3-thiazol-2-yl-urea (35 mg, 78%) was prepared from 1-[2-(2-fluoro-6-methoxy-phenoxy)-5-formyl-phenyl]-3-thiazol-2-yl-urea (39 mg, 0.1 mmol) and morpholine following the general procedure O.
Sources & evidence
- ORD record
- ord-34eb154bf317491f8a1556dbd61a96e1
- Source dataset
- uspto-grants-2011_03
- Patent number
- US07897628B2
Reaction notes
Loading…